High-performance liquid chromatographic analysis of desferrioxamine
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 433, 207-216
- https://doi.org/10.1016/s0378-4347(00)80599-x
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Pharmacokinetics and renal elimination of desferrioxamine and ferrioxamine in healthy subjects and patients with haemochromatosis.British Journal of Clinical Pharmacology, 1987
- Ocular Toxicity after a Single Intravenous Dose of Desferrioxamine in 2 Hemodialyzed PatientsNephron, 1987
- Visual and Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine InfusionsNew England Journal of Medicine, 1986
- Determination of desferoxamine and a major metabolite by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- EFFECT OF DESFERRIOXAMINE ON REMOVAL OF ALUMINIUM AND IRON BY COATED CHARCOAL HAEMOPERFUSION AND HAEMODIALYSISThe Lancet, 1983
- OCULAR TOXICITY OF HIGH-DOSE INTRAVENOUS DESFERRIOXAMINEThe Lancet, 1983
- Ethnic Differences in Drug MetabolismClinical Pharmacokinetics, 1982
- Continuous Subcutaneous Administration of Deferoxamine in Patients with Iron OverloadNew England Journal of Medicine, 1977
- SUBCUTANEOUS INFUSION AND INTRAMUSCULAR INJECTION OF DESFERRIOXAMINE IN PATIENTS WITH TRANSFUSIONAL IRON OVERLOADThe Lancet, 1976
- LONG‐TERM DESFERRIOXAMINE THERAPY IN THALASSEMIAAnnals of the New York Academy of Sciences, 1974